Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producingEscherichia coliO104:H4 in adults

Psychological Outcome, Fatigue, and Quality of Life After Infection With Shiga Toxin–Producing Escherichia coli O104

(2014) Bernd Löwe et al.   Clinical Gastroenterology and Hepatology

Childhood History of Resolved Glomerular Disease and Risk of Hypertension During Adulthood

(2014) Asaf Vivante et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure

(2014) Stefan Porubsky et al.   JOURNAL OF PATHOLOGY

Shiga Toxin Promotes Podocyte Injury in Experimental Hemolytic Uremic Syndrome via Activation of the Alternative Pathway of Complement

(2014) M. Locatelli et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Effects of Acute Kidney Injury on Long-Term Renal Function and Proteinuria in a General Hospitalised Population

(2014) Kerry L. Horne et al.   NEPHRON CLINICAL PRACTICE

Psychiatric Symptoms in Patients with Shiga Toxin-Producing E. coli O104:H4 Induced Haemolytic-Uraemic Syndrome

(2014) Alexandra Kleimann et al.   PLoS One

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab

(2013) Y. Delmas et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Quantitative MRI shows cerebral microstructural damage in hemolytic–uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI

(2013) Karin Weissenborn et al.   NEURORADIOLOGY

Long-term outcomes of Shiga toxin hemolytic uremic syndrome

(2013) Joann M. Spinale et al.   PEDIATRIC NEPHROLOGY

Dexamethasone Rescues Neurovascular Unit Integrity from Cell Damage Caused by Systemic Administration of Shiga Toxin 2 and Lipopolysaccharide in Mice Motor Cortex

(2013) Alipio Pinto et al.   PLoS One

The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak

(2012) Tim Magnus et al.   BRAIN

An Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Hemolytic Uremic Syndrome in Germany: Presentation and Short-term Outcome in Children

(2012) S. Loos et al.   CLINICAL INFECTIOUS DISEASES

Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli–Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae

(2012) Alejandra Rosales et al.   CLINICAL INFECTIOUS DISEASES

Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Associated With Organic Fenugreek Sprouts, France, June 2011

(2012) L. A. King et al.   CLINICAL INFECTIOUS DISEASES

Association Between Azithromycin Therapy and Duration of Bacterial Shedding Among Patients With Shiga Toxin–Producing Enteroaggregative Escherichia coli O104:H4

(2012) Martin Nitschke et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

(2012) Jan T. Kielstein et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

(2012) J. Menne et al.   BMJ-British Medical Journal

Early Volume Expansion During Diarrhea and Relative Nephroprotection During Subsequent Hemolytic Uremic Syndrome

(2011) Christina A. Hickey   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial

(2011) Andreas Greinacher et al.   LANCET

Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study

(2011) Edin Colic et al.   LANCET

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study

(2011) Martina Bielaszewska et al.   LANCET INFECTIOUS DISEASES

Eculizumab in Severe Shiga-Toxin–Associated HUS

(2011) Anne-Laure Lapeyraque et al.   NEW ENGLAND JOURNAL OF MEDICINE

Origins of theE. coliStrain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany

(2011) David A. Rasko et al.   NEW ENGLAND JOURNAL OF MEDICINE

Open-Source Genomic Analysis of Shiga-Toxin–ProducingE. coliO104:H4

(2011) Holger Rohde et al.   NEW ENGLAND JOURNAL OF MEDICINE

German Outbreak ofEscherichia coliO104:H4 Associated with Sprouts

(2011) Udo Buchholz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective

(2011) Markus J. Kemper   PEDIATRIC NEPHROLOGY

Prospective Genomic Characterization of the German Enterohemorrhagic Escherichia coli O104:H4 Outbreak by Rapid Next Generation Sequencing Technology

(2011) Alexander Mellmann et al.   PLoS One

Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children

(2011) Lars Krogvold et al.   Scandinavian Journal of Trauma Resuscitation & Emergency Medicine

Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction

(2010) Carla Zoja et al.   PEDIATRIC NEPHROLOGY

EnterohemorrhagicEscherichia coliO26:H11–Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation

(2010) Lothar-Bernd Zimmerhackl et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2

(2008) Kiyomi Takahashi et al.   Journal of Neuroinflammation

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)

(2008) Johanna Scheiring et al.   PEDIATRIC NEPHROLOGY